Kreaxi
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Seed, Early Stage, Series A, Series B
Geographical Focus
United Kingdom, Germany, France, Italy, Denmark, Switzerland, Spain, Ireland, Austria, Netherlands, Hungary, Portugal, Sweden, Belgium, Greece, Norway, Finland, Poland, Czech Republic, Romania, Bulgaria
Industries Focus
- Technology
- Healthcare
- Software
- EdTech
- FinTech
- Life Sciences
- Internet
- Agtech
- Cleantech
- Electronics
- Hardware
- Medical Technology
- Industry
- Digital
- Med Tech
Investment Size:
150,000 to 10,000,000 USD
Investor Details Founded: 2016
Kreaxi is an independent French investment management firm specializing in seed and venture capital. Born in 2016 from the merger of Rhône-Alpes Création and Banexi Ventures Partners, Kreaxi has over 30 years of experience in supporting innovative startups. The firm manages more than €500 million raised from institutional investors, backing over 550 companies, with 27 having gone public. ([kreaxi.com](https://www.kreaxi.com/en/company/?utm_source=openai))
Kreaxi focuses on early-stage investments, providing funding ranging from €150,000 to €10 million to support entrepreneurs in seed, acceleration, and development phases. The firm operates through various funds, including ARAC III, RAC II, R2V, BV5, and BV4, each targeting different stages and sectors. ([kreaxi.com](https://www.kreaxi.com/en/funds/?utm_source=openai))
With a team of 16 professionals based in Lyon and Paris, Kreaxi emphasizes proximity and trust with the entrepreneurs it supports. The firm is committed to responsible investment practices, integrating ESG criteria throughout its investment process and being a signatory of the UN Principles for Responsible Investment since 2014. ([kreaxi.com](https://www.kreaxi.com/en/company/?utm_source=openai))
Requirements
- Innovative and high-growth potential startups
- Strong founding team
- Sustainable competitive advantages
- Clear growth and exit potential within 5 to 7 years
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Sentryo
- Docea Power
- Amoeba
- Mathym
- Groupe Terresens
- Erytech Pharma
- Nanobiotix
- PX Therapeutics
- Wattsense
- Per Angusta
- Nukeygara
- Primo1D
Mentioned In
Claim this Investor
Are you an official representative of Kreaxi?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim